Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors

Published:2017-09 Issue: Volume:144 Page:159-166
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

De Simone Angela,Fiori Jessica,Naldi Marina,D’Urzo Annalisa,Tumiatti Vincenzo,Milelli Andrea,Andrisano Vincenza

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference38 articles.

1. From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease;Bolognesi;Mini Rev. Med. Chem.,2008

2. 3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the first dual BACE-1/GSK-3β fragment hits against Alzheimer's disease;Prati;ACS Chem. Neurosci.,2015

3. 2015 which new directions for Alzheimer's disease?;Latypova;Front. Cell. Neurosci.,2014

4. Recent developments of protein kinase inhibitors as potential AD therapeutics;Hilgeroth;Front. Cell. Neurosci.,2013

5. Alzheimer's disease is a synaptic failure;Selkoe;Science,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced analytical methodologies in Alzheimer’s disease drug discovery;Journal of Pharmaceutical and Biomedical Analysis;2020-01

2. Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks;ACS Medicinal Chemistry Letters;2019-08-26

3. Clinical Chemistry Route for Investigation of Alzheimer’s Disease: A Label-Free Electrochemiluminescent Biosensor for Glycogen Synthase Kinase-3 Beta;ACS Chemical Neuroscience;2019-07-19

4. Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35;RSC Advances;2019

5. Diabetes mellitus and Alzheimer’s disease: GSK-3β as a potential link;Behavioural Brain Research;2018-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3